Daniel E. Morse

Daniel E. Morse appears in our data through filings on Stellar Biotechnologies, Inc. shares, published by SEDI. We count 3 filings; the first trade dates from 26 June 2017 and the latest from 4 May 2018.

On the market, this insider has only sold: 1 sale, €2,216 in total. In 2018 alone, the filings show no purchases and 1 sale.

The newest entry dates from 9 August 2018: a transaction, in Stellar Biotechnologies, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.